In Memoriam: PDQ Board Member James Nachman
Dr. James B. Nachman, 62, who served for 13 years as a member of NCI's Physician Data Query (PDQ) Pediatric Treatment Editorial Board, died June 10 while on a rafting trip with friends in the Grand Canyon.
Dr. Nachman was an internationally renowned authority on the medical management of hematologic cancers in adolescents and young adults and an acknowledged expert in bone cancer and soft tissue sarcomas. He was a professor of Pediatrics and director of the Leukemia/Lymphoma Program at the University of Chicago Comer Children's Hospital.
Dr. Nachman was also a leader of the acute lymphoblastic leukemia (ALL) and lymphoma study committees of the Children's Oncology Group, which is part of NCI's Clinical Trials Cooperative Group Program. He was a member of the American Society of Hematology and the American Society of Pediatric Hematology/Oncology, as well as a co-founder of the International Ponte di Legno ALL Study Committee.
After graduating from the University of Illinois in 1970, Dr. Nachman went on to earn his medical degree from the Johns Hopkins University Medical School in 1974. He completed his residency in pediatrics and a fellowship in hematology/oncology at Children's Memorial Hospital in Chicago before joining the faculty of the University of Chicago as an assistant professor in 1980. He was promoted to associate professor of Clinical Pediatrics in 1985 and professor in 1999.
Survivors include his father, Dr. Adolph Nachman; his brother, Robert; and his sister, Cathy.
DCEG Training Program Receives Langmuir Award
NCI's Division of Cancer Epidemiology and Genetics (DCEG) last week won the inaugural Alexander D. Langmuir Award for Training Program Excellence and Innovation. Dr. Jackie Lavigne, chief of DCEG's Office of Education (OE), accepted the award during a ceremony at the 3rd North American Congress of Epidemiology in Montreal, Quebec, Canada.
The award highlights epidemiology training programs that emphasize research experience and skills development, the application of epidemiology principles and advanced methods, and the importance of collaborative and integrative epidemiologic approaches.
"This award acknowledges NCI's training program for having developed and implemented creative educational offerings that effectively train future leaders in epidemiology," said Dr. John Vena, the award committee chair.
Under the guidance of experienced mentors, DCEG fellows design and execute research studies, analyze data, and interpret and publish the results. DCEG also offers fellows practical opportunities to develop professional skills, including giving research presentations, planning scientific events, mentoring, and grant writing. Current and recent DCEG fellows are lead authors in most of the top journals in the field—evidence of the program's success.
The award honors the memory of Dr. Alexander D. Langmuir, who created the Epidemic Intelligence Service, a combined training and service program for epidemiologists at the Centers for Disease Control and Prevention.
NCAB Meeting Held This Week
The 158th meeting of the National Cancer Advisory Board (NCAB) was held yesterday and today on the NIH Campus in Bethesda, MD.
Dr. Harold Varmus opened the meeting with the NCI Director's Report. The board then heard presentations on a number of topics, including the Pharmacodynamics and Therapeutics Functional Working Group, the 12th Report on Carcinogens, and the results from NCI's National Lung Screening Trial.
NCI Hosts BSA Meeting June 20
NCI's Board of Scientific Advisors (BSA) met June 20 on the NIH campus in Bethesda, MD. In addition to a report from NCI Director Dr. Harold Varmus, the meeting included presentations on the cancer Bioinformatics Grid (caBIG) and NCI's Provocative Questions project. NCI Deputy Director for Clinical and Translational Research Dr. James Doroshow provided an update on the current shortage of drugs for cancer and other diseases.
In response to a request from the NCI director, BSA chair Dr. Richard Schilsky of the University of Chicago Pritzker School of Medicine reflected on his experience serving on the board for more than a decade. Among other remarks, Dr. Schilsky noted that there is "enormous talent" on the board and offered some thoughts about how NCI might best use this talent moving forward. A group discussion followed.
Dr. Schilsky and other board members who have completed their terms were recognized. These included Dr. Paul M. Allen of the Washington University School of Medicine in St. Louis; Dr. Christopher J. Logothetis of the University of Texas M. D. Anderson Cancer Center; Dr. Todd R. Golub of the Broad Institute; Dr. James K. Willson of the University of Texas Southwestern Medical Center; Dr. Jean Y. J. Wang of the University of California, San Diego, School of Medicine; and Dr. Edith A. Perez of the Mayo Clinic in Jacksonville, FL.
Telephone Workshop for Cancer Survivors to Focus on Late Effects
The final telephone workshop in the annual "Living With, Through, and Beyond Cancer" series will be held July 12 from 1:30 to 2:30 p.m. ET. Part IV of the series is titled "Fear of Recurrence and Late Effects: Living with Uncertainty."
The free series offers cancer survivors, their families, friends, and health care professionals practical information to help them cope with concerns and issues that arise after treatment ends. The workshops are presented by CancerCare in collaboration with NCI, LIVESTRONG, the American Cancer Society, the Intercultural Cancer Council, Living Beyond Breast Cancer, and the National Coalition for Cancer Survivorship.
Speakers for the July 12 workshop are Richard Dickens of CancerCare, Dr. Merle Mishel of the University of North Carolina at Chapel Hill, and Dr. David Spiegel of the Stanford University School of Medicine.
These workshops are free; no phone charges apply. To register, visit the CancerCare registration page.
Japanese Translators of the Bulletin Visit NCI
The staff of the NCI Cancer Bulletin met with Takako Tadokoro, vice president of the Japan Association of Medical Translation for Cancer, on June 10. The association translates NCI Cancer Bulletin articles and other NCI materials into Japanese. These translations, Tadokoro explained, provide information about cancer to ordinary people in Japan, where, she said, very little cancer information is available for a nonscientific audience.
Dr. Takefumi Komiya, a clinical fellow in NCI's Medical Oncology Branch and a volunteer translator, arranged the meeting.
Japanese readers may find the translations online.